About this trial
People living with human immunodeficiency virus (PLWH) have an estimated 1.6-6.0 times increased risk of developing oropharyngeal cancer (OPC) compared with individuals in the general population. 70% of OPCs are caused by human papillomavirus (HPV), and PLWH also have an increased prevalence of oral HPV infection. Disparities by race/ethnicity also include a later stage of diagnosis and less frequent cancer-directed treatment for members of ethnic minority groups. There is little known regarding the racial/ethnic differences in oral HPV infection, persistence of oral HPV infection, or progression of oral HPV infection to OPC among PLWH. This is an observational, prospective cohort study to investigate the feasibility of alternative sample collection methods for HPV testing among PLWH.
Eligibility criteria
Qualifiers
Over 35 years of age
Member of a sexual or gender group considered sexual minority men (men who have sex with men, trans-women)
Person living with HIV
Willing and able to receive a package through United States (US) postal service
Disqualifiers
Does not meet the above criteria
Trial design
Treatments tested in this trial
- Mail-based Saliva Sample Kit
- Study-related Surveys
Treatment groups
Sponsors and collaborators
University of California, San Francisco
Lead sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Collaborator